Filing Details

Accession Number:
0001144204-14-066508
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 16:25:02
Reporting Period:
2014-11-06
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 16:25:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Coronado Biosciences Inc CNDO Pharmaceutical Preparations (2834) 205157386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1038977 S Michael Weiss C/o Coronado Biosciences, Inc.
24 New England Executive Park
Burlington MA US 01803
Exec. Vc - Strategic Dev. Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2014-11-06 1,000,000 $1.61 6,938,038 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Options to purchase Common Stock $2.10 2023-12-19 30,000 30,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-12-19 30,000 30,000 Direct
Footnotes
  1. One-third of the shares will vest on each of December 19, 2014, 2015 and 2016.